Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 18, Issue 14, Pages 3924-3933

出版商

American Association for Cancer Research (AACR)

发表日期

2012-05-20

DOI

10.1158/1078-0432.ccr-11-2041

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started